<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_osteogenic" title="Icariin Promotes the Osteogenic Action of BMP2 by Activating the cAMP Signaling Pathway" shortTitle="osteogenic" author="Meng Chen, Yazhou Cui, Hui Li, Jing Luan, Xiaoyan Zhou, Jinxiang Han" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1420-3049/24/21/3875/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Bone	NN	bone
disorders	NNS	disorder
,	,	,
especially	RB	especially
osteoporosis	NN	osteoporosis
,	,	,
are	VBP	be
becoming	VBG	become
increasingly	RB	increasingly
prevalent	JJ	prevalent
as	IN	as
the	DT	the
aging	VBG	age
population	NN	population
grows	VBZ	grow
,	,	,
and	CC	and
bone	NN	bone
fractures	NNS	fracture
also	RB	also
occur	VBP	occur
frequently	RB	frequently
.	.	.
</s>
<s type="decl">
Osteoporosis	NN	osteoporosis
contributes	VBZ	contribute
significantly	RB	significantly
to	IN	to
global	JJ	global
healthcare	NN	healthcare
costs	NNS	cost
,	,	,
and	CC	and
the	DT	the
treatment	NN	treatment
of	IN	of
osteoporosis	NN	osteoporosis
remains	VBZ	remain
a	DT	a
great	JJ	great
challenge	NN	challenge
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
new	JJ	new
bone	NN	bone
anabolic	JJ	anabolic
drugs	NNS	drug
need	VBP	need
to	TO	to
be	VB	be
developed	VBN	develop
for	IN	for
the	DT	the
prevention	NN	prevention
and	CC	and
treatment	NN	treatment
of	IN	of
osteoporosis	NN	osteoporosis
.	.	.
</s>
</p>
<p>
<s type="decl">
Bone	NN	bone
morphogenetic	JJ	morphogenetic
protein	NN	protein
2	CD	2
(	-LRB-	(
BMP2	NNP	BMP2
)	-RRB-	)
is	VBZ	be
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
important	JJ	important
growth	NN	growth
factors	NNS	factor
that	WDT	that
induce	VBP	induce
osteoblast	NN	osteoblast
differentiation	NN	differentiation
and	CC	and
stimulate	VBP	stimulate
bone	NN	bone
or	CC	or
cartilage	NN	cartilage
formation	NN	formation
.	.	.
</s>
<s type="decl">
BMP2	NNP	BMP2
has	VBZ	have
been	VBN	be
widely	RB	widely
used	VBN	use
in	IN	in
the	DT	the
clinic	NN	clinic
to	TO	to
promote	VB	promote
bone	NN	bone
formation	NN	formation
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
therapeutic	JJ	therapeutic
dose	NN	dose
of	IN	of
BMP2	NN	BMP2
is	VBZ	be
very	RB	very
expensive	JJ	expensive
,	,	,
and	CC	and
there	EX	there
are	VBP	be
some	DT	some
life-threatening	NN	life-threatening
side	NN	side
effects	NNS	effect
that	WDT	that
can	MD	can
occur	VB	occur
with	IN	with
larger	JJR	large
doses	NNS	dose
.	.	.
</s>
<s type="decl">
Hence	RB	hence
,	,	,
it	PRP	it
is	VBZ	be
necessary	JJ	necessary
to	TO	to
find	VB	find
additional	JJ	additional
agents	NNS	agent
or	CC	or
methods	NNS	method
for	IN	for
the	DT	the
improvement	NN	improvement
of	IN	of
BMP2	NNP	BMP2
itself	PRP	itself
to	TO	to
intensify	VB	intensify
the	DT	the
osteogenic	JJ	osteogenic
effects	NNS	effect
of	IN	of
BMP2	NNP	BMP2
.	.	.
</s>
<s type="decl">
The	DT	the
combination	NN	combination
of	IN	of
BMP2	NN	BMP2
and	CC	and
these	DT	this
small	JJ	small
molecules	NNS	molecule
can	MD	can
promote	VB	promote
BMP2-mediated	NNP	BMP2-mediated
osteoblast	NN	osteoblast
differentiation	NN	differentiation
and	CC	and
reduces	VBZ	reduce
the	DT	the
risk	NN	risk
of	IN	of
its	PRP$	its
side	NN	side
effects	NNS	effect
in	IN	in
the	DT	the
treatment	NN	treatment
of	IN	of
bone	NN	bone
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
From	IN	from
a	DT	a
clinical	JJ	clinical
perspective	NN	perspective
,	,	,
these	DT	this
small	JJ	small
molecules	NNS	molecule
that	WDT	that
regulate	VBP	regulate
BMP2	NNP	BMP2
activity	NN	activity
provide	VBP	provide
powerful	JJ	powerful
tools	NNS	tool
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
osteoporosis	NN	osteoporosis
and	CC	and
fracture	NN	fracture
repair	NN	repair
.	.	.
</s>
</p>
<p>
<s type="decl">
Icariin	NNP	Icariin
(	-LRB-	(
ICA	NNP	ICA
)	-RRB-	)
(	-LRB-	(
the	DT	the
chemical	JJ	chemical
structure	NN	structure
is	VBZ	be
shown	VBN	show
in	IN	in
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
1	CD	1
</s>
</figure>
<s type="decl">
)	-RRB-	)
is	VBZ	be
the	DT	the
main	JJ	main
active	JJ	active
flavonoid	NN	flavonoid
glucoside	NN	glucoside
from	IN	from
herbs	NNS	herb
of	IN	of
the	DT	the
genus	NN	genus
<hi rend="italic">
Epimedium	NNP	Epimedium
</hi>
;	:	;
these	DT	this
herbs	NNS	herb
are	VBP	be
used	VBN	use
in	IN	in
traditional	JJ	traditional
Chinese	JJ	Chinese
medicine	NN	medicine
and	CC	and
have	VBP	have
long	RB	long
been	VBN	be
prescribed	VBN	prescribe
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
bone	NN	bone
fractures	NNS	fracture
and	CC	and
osteoporosis	NN	osteoporosis
as	IN	as
a	DT	a
bone-protecting	JJ	bone-protecting
agent	NN	agent
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
to	IN	to
promoting	VBG	promote
bone	NN	bone
regeneration	NN	regeneration
and	CC	and
repair	NN	repair
,	,	,
ICA	NNP	ICA
also	RB	also
has	VBZ	have
many	JJ	many
beneficial	JJ	beneficial
pharmacological	JJ	pharmacological
and	CC	and
biological	JJ	biological
activities	NNS	activity
,	,	,
including	VBG	include
neuroprotective	JJ	neuroprotective
effects	NNS	effect
;	:	;
protective	JJ	protective
effects	NNS	effect
against	IN	against
atherosclerosis	NN	atherosclerosis
;	:	;
antitumor	NN	antitumor
effects	NNS	effect
;	:	;
anti-inflammatory	JJ	anti-inflammatory
and	CC	and
antioxidant	JJ	antioxidant
effects	NNS	effect
;	:	;
and	CC	and
improved	VBN	improve
sexual	JJ	sexual
function	NN	function
effects	NNS	effect
.	.	.
</s>
<s type="decl">
Several	JJ	several
animal	NN	animal
and	CC	and
cell	NN	cell
studies	NNS	study
have	VBP	have
shown	VBN	show
that	IN	that
treatment	NN	treatment
with	IN	with
ICA	NNP	ICA
can	MD	can
increase	VB	increase
osteogenic	JJ	osteogenic
differentiation	NN	differentiation
and	CC	and
reduce	VB	reduce
bone	NN	bone
loss	NN	loss
in	IN	in
vivo	NN	vivo
and	CC	and
in	IN	in
vitro	NN	vitro
.	.	.
</s>
<s type="decl">
The	DT	the
extremely	RB	extremely
low	JJ	low
cost	NN	cost
of	IN	of
ICA	NNP	ICA
and	CC	and
its	PRP$	its
strong	JJ	strong
bone	NN	bone
regenerative	JJ	regenerative
effects	NNS	effect
indicate	VBP	indicate
its	PRP$	its
potential	NN	potential
in	IN	in
clinical	JJ	clinical
applications	NNS	application
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
cAMP/PKA/CREB	NN	camp/pka/creb
axis	NN	axis
is	VBZ	be
a	DT	a
vital	JJ	vital
pathway	NN	pathway
that	WDT	that
regulates	VBZ	regulate
osteogenic	JJ	osteogenic
differentiation	NN	differentiation
and	CC	and
mineralization	NN	mineralization
.	.	.
</s>
<s type="decl">
Several	JJ	several
previous	JJ	previous
studies	NNS	study
have	VBP	have
reported	VBN	report
that	IN	that
PTH	NNP	PTH
affects	VBZ	affect
osteoblastic	JJ	osteoblastic
cells	NNS	cell
by	IN	by
activating	VBG	activate
the	DT	the
cAMP/PKA/CREB	NNP	camprpKArcReB
axis	NN	axis
.	.	.
</s>
<s type="decl">
Several	JJ	several
studies	NNS	study
have	VBP	have
reported	VBN	report
that	IN	that
pretreatment	NN	pretreatment
of	IN	of
human	JJ	human
mesenchymal	NN	mesenchymal
stem	NN	stem
cells	NNS	cell
(	-LRB-	(
MSCs	NNS	MSC
)	-RRB-	)
with	IN	with
cAMP	NN	cAMP
analogs	NNS	analog
,	,	,
adenylate	NN	adenylate
cyclase	NN	cyclase
activators	NNS	activator
or	CC	or
phosphodiesterase	NN	phosphodiesterase
inhibitors	NNS	inhibitor
can	MD	can
enhance	VB	enhance
bone	NN	bone
formation	NN	formation
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
the	DT	the
present	JJ	present
study	NN	study
,	,	,
we	PRP	we
combined	VBD	combine
ICA	NNP	ICA
and	CC	and
BMP2	NNP	BMP2
to	TO	to
promote	VB	promote
osteogenesis	NN	osteogenesis
for	IN	for
the	DT	the
first	JJ	first
time	NN	time
.	.	.
</s>
<s type="decl">
We	PRP	we
aimed	VBD	aim
to	TO	to
determine	VB	determine
whether	IN	whether
ICA	NNP	ICA
could	MD	could
enhance	VB	enhance
the	DT	the
osteogenic	JJ	osteogenic
induction	NN	induction
of	IN	of
BMP2	NN	BMP2
in	IN	in
C2C12	NNP	C2C12
cells	NNS	cell
.	.	.
</s>
<s type="decl">
We	PRP	we
concluded	VBD	conclude
that	IN	that
the	DT	the
combination	NN	combination
of	IN	of
ICA	NNP	ICA
and	CC	and
BMP2	NNP	BMP2
could	MD	could
promote	VB	promote
BMP2-mediated	JJ	BMP2-mediated
osteoblast	NN	osteoblast
differentiation	NN	differentiation
in	IN	in
a	DT	a
dose-dependent	JJ	dose-dependent
manner	NN	manner
.	.	.
</s>
<s type="decl">
We	PRP	we
also	RB	also
found	VBD	find
that	IN	that
ICA	NNP	ICA
stimulates	VBZ	stimulate
BMP2-mediated	NNP	BMP2-mediated
osteogenesis	NN	osteogenesis
by	IN	by
activating	VBG	activate
the	DT	the
cAMP/PKA/CREB	NNP	camprpKArcReB
signaling	NN	signaling
pathway	NN	pathway
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
ICA	NNP	ICA
is	VBZ	be
a	DT	a
promising	JJ	promising
candidate	NN	candidate
as	IN	as
an	DT	a
alternative	NN	alternative
for	IN	for
BMP2	NNP	BMP2
or	CC	or
as	IN	as
a	DT	a
promoter	NN	promoter
for	IN	for
enhancing	VBG	enhance
the	DT	the
therapeutic	JJ	therapeutic
effects	NNS	effect
of	IN	of
BMP2	NNP	BMP2
.	.	.
</s>
<s type="decl">
This	DT	this
combination	NN	combination
will	MD	will
reduce	VB	reduce
the	DT	the
risk	NN	risk
of	IN	of
side	NN	side
effects	NNS	effect
from	IN	from
BMP2	NNP	BMP2
in	IN	in
the	DT	the
treatment	NN	treatment
of	IN	of
bone	NN	bone
diseases	NNS	disease
such	JJ	such
as	IN	as
osteoporosis	NN	osteoporosis
.	.	.
</s>
</p>
</text>